Received Apr 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Y019158 | IM |
PATIENT REPORTS DEVELOPING CELLULITIS AS A RESULT OF THIS VACCINE FOUR DAYS AFTER VACCINATION
No other illnesses reported
no known conditions
rosuvastatin, Decara, bupropion, alendronate, levothyroxine
NKDA
MD PRESCRIBED ABX IN RESPONSE